Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.
Dhingra, K
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. [electronic resource] - Cancer research Jul 1995 - 3060-7 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Adult
Aged
Antibiotics, Antineoplastic--adverse effects
Antibodies, Anti-Idiotypic--biosynthesis
Antibodies, Monoclonal--adverse effects
Antibody Formation--drug effects
Complement Activation--drug effects
Complement C3--metabolism
Complement C4--metabolism
Dose-Response Relationship, Drug
Drug Interactions
Female
Guanidines--adverse effects
Humans
Isoantigens--immunology
Male
Middle Aged
Neoplasms--drug therapy
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. [electronic resource] - Cancer research Jul 1995 - 3060-7 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Adult
Aged
Antibiotics, Antineoplastic--adverse effects
Antibodies, Anti-Idiotypic--biosynthesis
Antibodies, Monoclonal--adverse effects
Antibody Formation--drug effects
Complement Activation--drug effects
Complement C3--metabolism
Complement C4--metabolism
Dose-Response Relationship, Drug
Drug Interactions
Female
Guanidines--adverse effects
Humans
Isoantigens--immunology
Male
Middle Aged
Neoplasms--drug therapy